- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
Results
149
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
149 companies
Evolus
Market Cap: US$393.9m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$5.98
7D
-6.9%
1Y
-63.4%
Immuneering
Market Cap: US$383.7m
A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.
IMRX
US$8.00
7D
-11.2%
1Y
206.5%
Clover Biopharmaceuticals
Market Cap: HK$2.9b
A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.
2197
HK$2.26
7D
7.1%
1Y
707.1%
Absci
Market Cap: US$372.3m
Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.
ABSI
US$2.65
7D
-1.5%
1Y
-35.5%
DiaMedica Therapeutics
Market Cap: US$354.1m
A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
DMAC
US$6.84
7D
1.2%
1Y
59.1%
Galectin Therapeutics
Market Cap: US$304.3m
A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.
GALT
US$4.61
7D
-0.6%
1Y
74.0%
Vanda Pharmaceuticals
Market Cap: US$289.5m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.83
7D
6.9%
1Y
1.9%
Faron Pharmaceuticals Oy
Market Cap: UK£209.9m
Operates as a clinical stage drug discovery and development company.
FARN
UK£1.88
7D
0%
1Y
-12.8%
Transcenta Holding
Market Cap: HK$2.1b
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$4.60
7D
8.7%
1Y
342.3%
Aardvark Therapeutics
Market Cap: US$264.1m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$12.67
7D
12.2%
1Y
n/a
Quanterix
Market Cap: US$246.3m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$5.26
7D
-5.7%
1Y
-59.5%
3D Medicines
Market Cap: HK$1.8b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.50
7D
-7.3%
1Y
177.8%
Fennec Pharmaceuticals
Market Cap: US$233.8m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$8.70
7D
-2.6%
1Y
69.3%
OmniAb
Market Cap: US$227.4m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.56
7D
-6.0%
1Y
-63.1%
Tonix Pharmaceuticals Holding
Market Cap: US$216.5m
A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.
TNXP
US$24.00
7D
-15.4%
1Y
75.7%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.54
7D
2.8%
1Y
26.2%
Diaceutics
Market Cap: UK£137.9m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.63
7D
10.9%
1Y
22.1%
MaxCyte
Market Cap: US$177.0m
A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.
MXCT
US$1.53
7D
-5.6%
1Y
-60.7%
AFT Pharmaceuticals
Market Cap: NZ$293.6m
Develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.80
7D
7.3%
1Y
-12.5%
AVITA Medical
Market Cap: US$160.1m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$5.33
7D
-3.8%
1Y
-49.6%
Cassava Sciences
Market Cap: US$157.5m
A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
SAVA
US$3.10
7D
35.4%
1Y
-90.3%
Cybin
Market Cap: US$152.2m
A clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
US$5.86
7D
-2.3%
1Y
-40.7%
Shattuck Labs
Market Cap: US$148.4m
A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.
STTK
US$2.29
7D
2.7%
1Y
-38.4%
Auxly Cannabis Group
Market Cap: CA$202.3m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.15
7D
3.4%
1Y
328.6%
Cardiff Oncology
Market Cap: US$137.7m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$2.04
7D
-5.6%
1Y
-26.1%
Tetratherix
Market Cap: AU$208.9m
Engages in biomaterial and regenerative medicine business in Australia and internationally.
TTX
AU$4.15
7D
-4.2%
1Y
n/a
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 25.70
7D
0.8%
1Y
45.4%
Oncolytics Biotech
Market Cap: US$125.5m
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.
ONCY
US$1.25
7D
-8.1%
1Y
39.3%
eXoZymes
Market Cap: US$122.5m
Operates as a development stage biotechnology company.
EXOZ
US$14.57
7D
5.9%
1Y
n/a
Anixa Biosciences
Market Cap: US$113.2m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$3.38
7D
0.1%
1Y
6.1%
Oncopeptides
Market Cap: SEK 1.1b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 4.69
7D
-1.4%
1Y
113.9%
MacroGenics
Market Cap: US$108.7m
A clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States.
MGNX
US$1.65
7D
-4.6%
1Y
-45.7%
Nautilus Biotechnology
Market Cap: US$91.0m
A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
NAUT
US$0.82
7D
12.8%
1Y
-71.2%
Hemogenyx Pharmaceuticals
Market Cap: UK£67.8m
A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.
HEMO
UK£12.65
7D
-18.1%
1Y
79.2%
ECO Animal Health Group
Market Cap: UK£66.7m
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.
EAH
UK£0.98
7D
14.5%
1Y
-4.4%
Helix BioPharma
Market Cap: CA$121.4m
Operates as an immune-oncology company in Canada.
HBP
CA$1.52
7D
0.7%
1Y
27.7%